Active substance
Isosorbide 5
- Health Canada 4
- UK MHRA 32
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-ISMN | 02272830 | 60 MG | TABLET (EXTENDED-RELEASE) · ORAL | APOTEX INC |
| PMS-ISMN | 02301288 | 60 MG | TABLET (EXTENDED-RELEASE) · ORAL | PHARMASCIENCE INC |
| PRO-ISMN - 60 | 02311321 | 60 MG | TABLET (EXTENDED-RELEASE) · ORAL | PRO DOC LIMITEE |
| PRZ-ISMN | 02562561 | 60 MG | TABLET (EXTENDED-RELEASE) · ORAL | PHARMARIS CANADA INC |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| CARMIL 20 MG TABLETS | PL 16363/0001 | MILPHARM LIMITED | P |
| CARMIL 40 MG TABLETS | PL 16363/0002 | MILPHARM LIMITED | P |
| CARMIL XL TABLETS | PL 16363/0003 | MILPHARM LIMITED | P |
| CHEMYDUR 60XL | PL 20072/0220 | AMDIPHARM UK LIMITED | P |
| EUMON 25XL | PL 28444/0208 | ACTIVASE PHARMACEUTICALS LIMITED | P |
| EUMON 30XL | PL 28444/0209 | ACTIVASE PHARMACEUTICALS LIMITED | P |
| EUMON 40XL | PL 11311/0455 | TILLOMED LABORATORIES LIMITED | P |
| EUMON 50XL | PL 28444/0210 | ACTIVASE PHARMACEUTICALS LIMITED | P |
| EUMON 60 XL | PL 11311/0457 | TILLOMED LABORATORIES LIMITED | P |
| ISODUR 25XL CAPSULES | PL 27827/0021 | GALEN LIMITED | P |
| ISODUR 50XL CAPSULES | PL 27827/0022 | GALEN LIMITED | P |
| ISOSORBIDE MONONITRATE 20 MG TABLETS | PL 16363/0001 | MILPHARM LIMITED | P |
| ISOSORBIDE MONONITRATE 20MG TABLETS | PL 04556/0057 | PHARMVIT LIMITED | P |
| ISOSORBIDE MONONITRATE 20MG TABLETS | PL 21880/0117 | MEDREICH PLC | P |
| ISOSORBIDE MONONITRATE 40 MG TABLETS | PL 16363/0002 | MILPHARM LIMITED | P |
| ISOSORBIDE MONONITRATE 40MG TABLETS | PL 21880/0118 | MEDREICH PLC | P |
| ISOSORBIDE MONONITRATE KENT 40MG XL TABLETS | PL 51463/0028 | KENT PHARMA UK LIMITED | P |
| ISOTARD 25 MG XL TABLETS | PL 44616/0006 | EVOLAN PHARMA AB | P |
| ISOTARD 40MG XL TABLETS | PL 44616/0007 | EVOLAN PHARMA AB | P |
| ISOTARD 50MG XL TABLETS | PL 44616/0008 | EVOLAN PHARMA AB | P |
| ISOTARD 60MG XL TABLETS | PL 44616/0009 | EVOLAN PHARMA AB | P |
| MEDOMON XL 60MG PROLONGED RELEASE TABLETS | PL 49565/0025 | RUDIPHARM LIMITED | P |
| MITRATE 60XL | PL 20072/0220 | AMDIPHARM UK LIMITED | P |
| MODISAL XL 40MG PROLONGED RELEASE TABLETS | PL 55612/0014 | ENNOGEN IP LTD | P |
| MONOMAX XL 60 MG TABLETS | PL 08829/0102 | CHIESI LIMITED | P |
7 more — full table
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.